Biotech Values

[ciotera]

Yeah there's a statistical difference and it's meaningful.

That's certainly what ABBV would like you to believe - 6% failure vs. 3% failure is twice as many failures :) For me personally, anything above 90% is good enough - at that point the efficacy hurdle is met and I look for the lower level benefits like tolerability, convenience and cost.